Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1723

BillFederalSenateIn Committee
Budgeting for Opioid Addiction Treatment Act
About This Bill
Committee
Latest Action · May 20, 2021
Read twice and referred to the Committee on Finance.
Congress
117th (2021–2023)
Introduced
May 20, 2021
Cosponsors (10)
8D 1R
View PDF ↗

Summary

Highlight any text to annotate
Budgeting for Opioid Addiction Treatment Act This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof. The bill provides block grants for substance abuse treatment programs. The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.